Operational blind spots cost margins and elevate risks for manufacturers. We explore how teams can see these familiar ...
Claude Science is designed to streamline scientific research by consolidating fragmented tools and databases into a single, ...
A secret new energy gel containing lactate has been bought out by a single Tour de France team. Discover the sports nutrition ...
Preclinical realities, therapeutic momentum, and generative AI in drug discovery ...
Since 2017, Iason Gabriel has worked at the tech giant, trying to anticipate – and think through – the impact of AI. But as commercial and geopolitical pressures escalate, can ethicists make any ...
Discover why animal models fall short in AI drug discovery and how human-first datasets and functional genomics are changing ...
A slew of start-ups and academic labs are leaning on AI agents and bots, rather than humans, to speed up their chemistry ...
Geneva researchers are repurposing existing drugs for rare diseases, offering new hope where options are scarce.
Anthropic is pricing both Fable 5 and Mythos 5 at $10 per million input tokens and $50 per million output tokens. The company says that is less than half the price of Claude Mythos Preview ...
Morning Overview on MSN
A huge Lancet study says statins don’t cause most of the side effects on their labels
Millions of people who take statins for heart disease prevention have been warned about dozens of possible side effects on ...
As you all know, Alnylam is pioneering an entirely new class of medicines to treat human disease. This generational technology leverages the mechanism of RNA interference, a natural process of gene ...
Introduction Mental health is an urgent public health issue with social and economic relevance. Business families play a key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results